Recent Finacing
Recent Raise
Emerge Diagnostics provides the FDA Class II EFA electrodiagnostic test and EFA-STM program for employers and occupational clinics to diagnose, localize, age, monitor soft-tissue injuries and assess malingering.
Focus Areas
Total Raised
Funding round